Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc.

NASDAQ:MNMD

Overview | Financials
Company Name Mind Medicine (MindMed) Inc.
Symbol MNMD
Currency USD
Price 7.08
Market Cap 519,188,337
Dividend Yield 0%
52-week-range 3.49 - 12.22
Industry Biotechnology
Sector Healthcare
CEO Mr. Robert Barrow
Website https://www.mindmed.co

An error occurred while fetching data.

About Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the

Related Stocks

Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

ABUS

3.19 USD

Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

OTLK

1.42 USD

Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc.

RIGL

17.15 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

9.25 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

76.79 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.513 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

4.68 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.346 USD

Financials

Numbers are in millions USD

Numbers are in millions USD